TCR2 Therapeutics

-$0.05 (-2.31%) Today
-$0.01 (-0.47%) As of 9:59 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TCRR and other ETFs, options, and stocks.

About TCRR

TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development.

CEO
Garry E. Menzel
Employees
137
Headquarters
Cambridge, Massachusetts
Founded
2015

TCRR Key Statistics

Market cap
81.33M
Price-Earnings ratio
—
Dividend yield
—
Average volume
423.30K
High today
$2.21
Low today
$2.09
Open price
$2.17
Volume
461.71K
52 Week high
$19.85
52 Week low
$2.09

TCRR Earnings

-$0.76
-$0.51
-$0.25
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$0.76 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure